Skip to content

Clinical trials

Neoplasms, Glandular and Epithelial trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms, Glandular and Epithelial Country / region: China Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20141
20151
20162
20171
20202
20212
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status5
Completed4
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sumitomo Pharma America, Inc.2
Xiaoxiang Chen2
Abbott1
Guangxi Medical University1
Hoffmann-La Roche1
Imunon1
Qingdao Central Hospital1
Shandong Cancer Hospital and Institute1
Shanghai Zhongshan Hospital1
Wenjun Cheng1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms, Glandular and Epithelial12
Neoplasms by Histologic Type9
Neoplasms by Site9
Adenocarcinoma7
Carcinoma7
Digestive System Neoplasms7
Neoplasms7
Carcinoma, Hepatocellular5
Digestive System Diseases5
Liver Neoplasms5

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.